Peptide Profit Frenzy Accelerates

A wave of companies are aggressively marketing peptide-based products as anti-aging and wellness treatments, capitalizing on limited regulation and consumer excitement. The trend risks widespread financial waste and overshadows legitimate research into peptide therapies, which require more rigorous clinical validation.

Sources (1)